1h Free Analyst Time
This report offers market size & forecast data for the global syringes & needles market. The revenue generated from the sale of syringes & needles is included in the report. The cost of drugs, vaccines, and other medications are excluded from the scope of the report. This report provides a comprehensive and current market scenario of the global syringes & needles market, including the global syringes & needles market size, anticipated market forecast, relevant market segmentations, and industry trends. Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present global syringes & needles market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
Key Highlights
- The global syringes & needles market was valued at $29.85 billion in 2023 and is expected to reach $47.20 billion by 2029, growing at a CAGR of 7.93%.
- The demand for syringes & needles is on the rise due to multiple factors: an increasing geriatric population, growing consumer awareness regarding usage, high prevalence of chronic cases, and increasing adoption of syringes and needles in treating diabetes.
- In 2023, North America accounted for a significant revenue share of 30.68% and was the largest market, followed by Europe (28.45%), APAC (26.00%), Latin America (9.74%), and then Middle-East and Africa (5.13%) in global syringes & needles market.
- By Product type segmentation, the Syringes segment accounted for the highest share of 66.89% in 2023 and is projected to grow at the CAGR of 8.16% during the forecast period. Factors such as demand for prefilled syringes, the rise in prevalence of chronic diseases, and growing awareness of usage are propelling the growth of the segment.
- In end-user segmentation, the hospitals segment accounted for the highest share of 57.77% in 2023 and is projected to grow at the CAGR of 8.36% during the forecast period. This dominance can be attributed to the rise in the prevalence of chronic diseases, the increasing geriatric population, and a rise in surgeries across the world.
- By Patient group, the adults segment accounted for the highest share of 69.25% in 2023 and is projected to grow at the CAGR of 8.17% during the forecast period. The dominance is due to the rise in the geriatric population, the increasing prevalence of chronic diseases, such as diabetes & infectious diseases like HIV infections, rise in the incidence of wounds, injuries, and surgeries in adults are some factors driving the segment growth.
- BD, Cardinal Health, B Braun, Nipro, and Terumo Corp are some of the leading players currently dominating the global syringes & needles market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the syringes & needles market and gain access to commercially launched products.
PRODUCT SEGMENTATION & FORECAST
Product type
- Syringes (Disposable, Sterilizable)
- Needles
End-user type
- Hospitals
- Clinics
- Home Healthcare Settings
- Others
Patient Group
- Adults
- Pediatrics
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of Syringes & Needles Market
- Key Vendors
- Other Prominent Vendors
APPENDIX
- Research Methodology
- Abbreviations
VENDORS LIST
- BD
- B Braun
- HMD Healthcare
- Nipro Medical
- Terumo
- Cardinal Healthcare
- Asahi Polyslider
- Cartel Healthcare
- Changzhou Mingle Medical Equipment
- Misawa Medical Industry Co., Ltd
- Fanmei Medical
- Henke Sass Wolf
- HI-TECH Medics
- Iscon Surgicals Ltd
- Kanghua Medical
- Kangjin
- Lepu Medical
- Lifelong Medtech
- M Devices
- Metier Medical
- Numedico Technologies
- ADVACARE
- ALLISION MEDICALS
- ARGON MEDICAL DEVICES
- ASPEN SURGICAL
- ATS LIFE SCIENCES
- Baxter
- CODAN
- CREDENCE MEDSYSTEMS
- DALI MEDICAL DEVICES
- DE ROYAL
- EXELINT
- GERREISHEIME
- VYGON SA
- INTERNATIONAL MEDSURG
- MEDTRONIC
- MHC MEDICAL
- NEMERA
- NOVO NORDISK
- TELEFLEX
- RETRACTABLE TECHNOLOGIES
- SCHOTT Pharma
- SHL Medical
- VITA NEEDLE COMPANY
- WEST Pharmaceuticals
- ICU Medical
- Artasana SPA
- APEXMED
- CONMED
- CONNECTICUT HYPODERMICS
- CATALENT Biologics
- Delta Med
- Hamilton Company
- Merit Medical Systems
- UltiMed
- YpsoMed
Table of Contents
Chapter - 1: Syringes & Needles Market Overview
Chapter - 2: Syringes & Needles Market
Chapter - 3: Syringes & Needles Market Segmentation Data
Chapter - 4: Key Regions Overview
Chapter - 5: Syringes & Needles Market Prospects & Opportunities
Chapter - 6: Syringes & Needles Industry Overview
Chapter - 7: Appendix
List of Exhibits
List of Tables
Companies Mentioned
- BD
- B Braun
- HMD Healthcare
- Nipro Medical
- Terumo
- Cardinal Healthcare
- Asahi Polyslider
- Cartel Healthcare
- Changzhou Mingle Medical Equipment
- Misawa Medical Industry Co. Ltd.
- Fanmei Medical
- Henke Sass Wolf
- HI-TECH Medics
- Iscon Surgicals Ltd.
- Kanghua Medical
- Kangjin
- Lepu Medical
- Lifelong Medtech
- M Devices
- Metier Medical
- Numedico Technologies
- ADVACARE
- ALLISION MEDICALS
- ARGON MEDICAL DEVICES
- ASPEN SURGICAL
- ATS LIFE SCIENCES
- Baxter
- CODAN
- CREDENCE MEDSYSTEMS
- DALI MEDICAL DEVICES
- DE ROYAL
- EXELINT
- GERREISHEIME
- VYGON SA
- INTERNATIONAL MEDSURG
- MEDTRONIC
- MHC MEDICAL
- NEMERA
- NOVO NORDISK
- TELEFLEX
- RETRACTABLE TECHNOLOGIES
- SCHOTT Pharma
- SHL Medical
- VITA NEEDLE COMPANY
- WEST Pharmaceuticals
- ICU Medical
- Artasana SPA
- APEXMED
- CONMED
- CONNECTICUT HYPODERMICS
- CATALENT Biologics
- Delta Med
- Hamilton Company
- Merit Medical Systems
- UltiMed
- YpsoMed
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 133 |
| Published | October 2023 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value ( USD | $ 29.85 Billion |
| Forecasted Market Value ( USD | $ 47.2 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 56 |
